找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Urticaria and Angioedema; Torsten Zuberbier,Clive Grattan,Marcus Maurer Book 2021Latest edition Springer Nature Switzerland AG 2021 Dermat

[复制链接]
楼主: 粗略
发表于 2025-3-26 21:52:37 | 显示全部楼层
Omalizumab in the Treatment of Urticaria,vere asthma since 2003, for adults and adolescents with chronic spontaneous urticaria unresponsive to antihistamines since 2014. The evidence base for its efficacy and safety in chronic urticaria is strong. Its introduction has changed the outlook for patients with chronic spontaneous urticaria not
发表于 2025-3-27 03:50:48 | 显示全部楼层
Other Interventions for Chronic Urticaria,malizumab, approved for chronic spontaneous urticaria in 2014. Other interventions with low evidence have been used by specialists for decades to manage patients who do not respond to H1 antihistamines. Pharmacological interventions include oral corticosteroids, H2 antihistamines, anti-leukotrienes,
发表于 2025-3-27 08:36:14 | 显示全部楼层
发表于 2025-3-27 10:18:10 | 显示全部楼层
Urticaria Therapy and Management. Looking Forward,nt pathogenic and therapeutic advances in urticaria represent an extremely and desired benefit for CU patients and imply recognized improvement in the quality of CU management. The rationale of the new treatments shows therapeutic targets acting through different mechanisms involved in the wheal pat
发表于 2025-3-27 15:13:24 | 显示全部楼层
发表于 2025-3-27 20:34:41 | 显示全部楼层
发表于 2025-3-27 23:40:27 | 显示全部楼层
Classification and Diagnosis of Urticaria,hey are inducible. Disease activity and level of symptoms must also be considered when assessing the severity of urticaria, and for this the UAS7 patient self-assessment is used. Acute, chronic, and spontaneous chronic urticaria also differ in the diagnostic work up.
发表于 2025-3-28 02:08:16 | 显示全部楼层
Management Principles in Urticaria,c treatment using pharmacological agents is however often the only practical approach and comprises non-sedating antihistamines as first-line, their updosing as second-line and add-on of other agents as third- and fourth-line treatment options.
发表于 2025-3-28 08:51:27 | 显示全部楼层
发表于 2025-3-28 13:41:37 | 显示全部楼层
Impact of Chronic Urticaria and How to Measure It,ity scores and quality of life questionnaires provide important insights from the patient perspective. The urticaria and angioedema control tests help to distinguish well-controlled from poorly controlled disease and to determine the need for treatment adjustments. The clinical pattern of chronic in
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-2 10:22
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表